SpectraScience Inc (SCIE)-医療機器分野:企業M&A・提携分析

◆英語タイトル:SpectraScience Inc (SCIE) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011935
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SpectraScience Inc (SpectraScience) is a medical device company, which undertakes the design, development, manufacture and marketing of light-based technology products. The company offers its proprietary WavSTAT Optical Biopsy System to diagnose tissue health optically by using light. This system is mainly used in diagnosing colorectal cancer and also plans to extend its application to esophageal, bladder, lung and other cancers. SpectraScience has developed two products, namely, the WavSTAT mobile console and optical biopsy forceps based on this technology. The company markets its WavSTAT System in the international markets through a distribution agreement with PENTAX Europe GmbH. SpectraScience is headquartered in San Diego, California, the US.

SpectraScience Inc (SCIE) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SpectraScience Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
SpectraScience Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
SpectraScience Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
SpectraScience Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
SpectraScience Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
SpectraScience Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
SpectraScience Acquires Assets of Oncoscope 10
Venture Financing 11
Oncoscope Raises US$0.45 Million In Venture Financing 11
Oncoscope Secures An Additional US$1.1 Million In Financing 12
Partnerships 13
SpectraScience And Pentax Europe Expand Distribution Agreement For WavStat4 Optical Biopsy System 13
SpectraScience Enters Into Distribution Agreement With Pentax Europe 14
SpectraScience Expands Licensing Agreement with Duke University 15
Debt Offering 16
Spectrascience Completes Private Placement Of Debentures For US$0.05 Million 16
SpectraScience Completes Fourth Tranche Of Private Placement Of Debentures For US$0.85 Million 17
SpectraScience Completes Private Placement Of Convertible Debentures For US$0.27 Million 18
SpectraScience Completes Private Placement Of Convertible Debentures For US$0.83 Million 19
SpectraScience Completes Private Placement Of Convertible Debentures For US$0.4 Million 20
SpectraScience Completes Private Placement Of Convertible Debentures For US$0.6 Million 21
Asset Transactions 22
SpectraScience Acquires Assets of Oncoscope 22
SpectraScience Inc – Key Competitors 23
SpectraScience Inc – Key Employees 24
SpectraScience Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Product News 26
02/02/2016: SpectraScience Announces Publication of Clinical Data 26
01/19/2016: SpectraScience to Display WavSTAT Optical Biopsy System at Arab Health Conference 27
Other Significant Developments 28
Jul 19, 2016: SpectraScience Appoints AMG as Exclusive Distributor in Middle East 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
SpectraScience Inc, Medical Equipment, Key Facts, 2016 2
SpectraScience Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
SpectraScience Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
SpectraScience Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
SpectraScience Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
SpectraScience Inc, Deals By Market, 2011 to YTD 2017 8
SpectraScience Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
SpectraScience Acquires Assets of Oncoscope 10
Oncoscope Raises US$0.45 Million In Venture Financing 11
Oncoscope Secures An Additional US$1.1 Million In Financing 12
SpectraScience And Pentax Europe Expand Distribution Agreement For WavStat4 Optical Biopsy System 13
SpectraScience Enters Into Distribution Agreement With Pentax Europe 14
SpectraScience Expands Licensing Agreement with Duke University 15
Spectrascience Completes Private Placement Of Debentures For US$0.05 Million 16
SpectraScience Completes Fourth Tranche Of Private Placement Of Debentures For US$0.85 Million 17
SpectraScience Completes Private Placement Of Convertible Debentures For US$0.27 Million 18
SpectraScience Completes Private Placement Of Convertible Debentures For US$0.83 Million 19
SpectraScience Completes Private Placement Of Convertible Debentures For US$0.4 Million 20
SpectraScience Completes Private Placement Of Convertible Debentures For US$0.6 Million 21
SpectraScience Acquires Assets of Oncoscope 22
SpectraScience Inc, Key Competitors 23
SpectraScience Inc, Key Employees 24
SpectraScience Inc, Subsidiaries 25

★海外企業調査レポート[SpectraScience Inc (SCIE)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cabot Oil & Gas Corp (COG):企業の財務・戦略的SWOT分析
    Cabot Oil & Gas Corp (COG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • XTL Biopharmaceuticals Ltd (XTLB):企業の財務・戦略的SWOT分析
    Summary XTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin …
  • Alten SA:企業の戦略・SWOT・財務情報
    Alten SA - Strategy, SWOT and Corporate Finance Report Summary Alten SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • The Credit Mutuel-Cic Group:企業の戦略・SWOT・財務分析
    The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report Summary The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Ignyta Inc (RXDX)-製薬・医療分野:企業M&A・提携分析
    Summary Ignyta Inc (Ignyta), formerly NexDx Inc is a drug manufacturing company that discovers, develops and commercializes new drugs targeting activated genes in cancer cells for the treatment of cancer patients. The company develops products using integrated therapeutic (Rx) and companion diagnost …
  • The Clorox Company (CLX):企業の財務・戦略的SWOT分析
    The Clorox Company (CLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Adverum Biotechnologies Inc (ADVM):製薬・医療:M&Aディール及び事業提携情報
    Summary Adverum Biotechnologies Inc (Adverum), formerly Avalanche Biotechnologies Inc, is a clinical-stage gene therapy provider. The company’s product pipeline includes AVDM-053, ADVM-022 and AVA-311. Its products are used for treatment of antitrypsin deficiency, hereditary angioedema, wet age-rela …
  • Societe Electrique de l’Our SA:企業の戦略的SWOT分析
    Societe Electrique de l'Our SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Kimball International, Inc.
    Kimball International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kimball International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • M.M.Warburg & CO KGaA:企業の戦略・SWOT・財務情報
    M.M.Warburg & CO KGaA - Strategy, SWOT and Corporate Finance Report Summary M.M.Warburg & CO KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • BCE Inc.:企業の戦略・SWOT・財務情報
    BCE Inc. - Strategy, SWOT and Corporate Finance Report Summary BCE Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Eternygen GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Eternygen GmbH (Eternygen) focuses on research and development of innovative drugs for dietary-related metabolic diseases.The company’s product development portfolio includes novel small molecule inhibitors, developed against the sodium coupled citrate transporter NaCT. It focuses research o …
  • AltaGas Ltd.:企業のM&A・事業提携・投資動向
    AltaGas Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AltaGas Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • AECOM (ACM):企業の財務・戦略的SWOT分析
    AECOM (ACM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the poten …
  • FleetCor Technologies Inc:企業の戦略・SWOT・財務分析
    FleetCor Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary FleetCor Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • The Hershey Co:戦略・SWOT・企業財務分析
    The Hershey Co - Strategy, SWOT and Corporate Finance Report Summary The Hershey Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • ICU Medical Inc (ICUI):医療機器:M&Aディール及び事業提携情報
    Summary ICU Medical Inc (ICU Medical) is a medical device company which develops, manufactures, distributes and sells devices used for infusion therapy, cancer diagnosis and treatment and critical care applications. The company’s major products include needle free vascular access devices, closed sys …
  • Bajaj Finserv Limited:企業の戦略・SWOT・財務情報
    Bajaj Finserv Limited - Strategy, SWOT and Corporate Finance Report Summary Bajaj Finserv Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Harvard Stem Cell Institute-製薬・医療分野:企業M&A・提携分析
    Summary Harvard Stem Cell Institute (HSCI), a subsidiary of Harvard University is a healthcare institute that conducts research on advance stem cell science using stem cell biology to develop new treatments and cures for disease. The institute provides research programs such as disease programs, cor …
  • Western Farmers Electric Cooperative:発電所・企業SWOT分析
    Western Farmers Electric Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆